MEMBER'S LOGINX
| Invalid Username / Password | ||||||||
| Invalid Captcha | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
India's Third Giant Leap
This Could be One of the Biggest Opportunities for Investors
- Home
- Todays Market
- Indian Stock Market News January 9, 2020
Sensex Climbs 550 Points; SBI & IndusInd Bank Top Gainers Thu, 9 Jan 12:30 pm
Share markets in India have extended early gains and are presently trading on a strong note. Benchmark indices jumped sharply today amid no further fresh escalation in geopolitical conflicts in the Middle East.
All sectoral indices are trading in green with stocks in the realty sector, banking sector and automobile sector witnessing most of the buying interest.
The BSE Sensex is trading up by 553 points, up 1.4%, while the NSE Nifty is trading up by 164 points.
The <>BSE MidCap Index and the <>BSE SmallCap Index are trading higher by 1.4% and 1.5%, respectively.
In news from the realty sector, shares of Sunteck Realty surged over 6% today after the real estate developer entered into a memorandum of understanding (MoU) with State Bank of India (SBI) to safeguard home buyers financially under Residential Builder Finance with Buyer Guarantee programme.
Under the scheme, SBI will issue guarantee for completion of projects to customers availing SBI Home Loans.
The programme focuses on house segments with home price of up to Rs 25 million in seven Indian geographies.
In a statement to exchanges, the real estate developer said that all reputed builders fulfilling the prescribed criteria, including meeting Star rating and CIBIL score, by the bank can avail loan between Rs 0.5 billion to Rs 4 billion.
Under the MoU, the state lender would refund the buyer's amount invested in an under-construction project if the builder fails to handover the occupancy certificate within the agreed time period.
This time-period cut-off is based on the timeline submitted to RERA (Real Estate Regulation and Development Authority), making it an additional cover over and above RERA.
Sunteck Realty share price is presently trading up by 4.6%.
Speaking of real estate sector, note that this is one sector that has tested investor patience over the years. While the sector has seen big moves in the last few years, the downward movement has been equally sharp.
The post demonetisation era has been tough on the sector. Excess inventory, i.e. housing projects stuck for years, has meant homeowners have largely stayed away from any fresh buying in the real estate space.
Also, post the IL&FS crisis, lending to real estate developers has largely dried up. The BSE Realty Index also reflects the same. It was down 31% in 2018.
But is the scenario about to change?
The government recently announced a Rs 250 billion package to bailout stalled housing projects. It's a much-needed relief for homeowners.
The government plans to revive over 1,600 stalled housing projects covering 4.6 lakh units.
Announcing the decision, Finance Minister Nirmala Sitharaman had said the government will put in Rs 100 billion in this alternative investment fund (AIF) while SBI and LIC would provide Rs 150 billion, taking the total size to Rs 250 billion.
Is the Real Estate Sector Set for a Turnaround?
The BSE Realty Index has seen a sharp bounce post this announcement.
What would be more interesting is the pickup in consumption once the real estate sector revives.
Once people get their homes, they are likely to spend on tiles, paints, furniture, electronics, pipes, cables, cement, and many other things.
Watch this space for more!
Moving on to news from the pharma sector, Alembic Pharma share price is in focus today.
The company's joint venture firm, Aleor Dermaceuticals has completed United States Food and Drug Administration (USFDA) inspection at its formulation manufacturing facility located at Karakhadi, Gujarat without any observations.
Shares of the company surged around 3% on back of the above news.
The inspection was carried out from January 6 to January 8.
Aleor Dermaceuticals is a 60:40 joint venture between Alembic Pharmaceuticals and Orbicular Pharmaceutical Technologies.
In other news, shares of Aster DM Healthcare jumped 6% intraday ahead of its board's meeting on a proposed share buyback later in the day.
Aster DM Healthcare share price is presently trading up by 2%.
Speaking of the pharma sector, in the video below, Tanushree talks in great detail about the pharma sector.
She tells us where the sector stands now and also about the potential for a rebound.
Tune in to find out more...
To know what's moving the Indian stock markets today, check out the most recent share market updates here.
For information on how to pick stocks that have the potential to deliver big returns, download our special report now!
Read the latest Market Commentary
Indian Share Market Update: Top Gainers and Losers
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
- Multibagger Penny Stocks
- Basics of Value Investing
- Benjamin Graham
- How to Invest in Gold
- How to Invest in Silver
- Best Stocks to Buy Today
- Best Small-cap Stocks to Buy
- Best Bluechip Stocks to Buy
- Guide to Penny Stocks
- How to Invest in the Share Market
- Warren Buffett - The Value Investor
- Pick the Best Multibagger Stocks
TRENDING TOPICS
Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407
Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com
LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
Equitymaster requests your view! Post a comment on "Sensex Climbs 550 Points; SBI & IndusInd Bank Top Gainers". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!